GENERAL MOTORS (GM)
Sector: Consumer Discretionary
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Consumer Discretionary
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for GM
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| GM | Co-Founder and Managing Director, Aditum Bio | 66 | ["Co-Founder and Managing Director, Aditum Bio","Co-Founder and Managing Director of Aditum Bio","Former CEO of Novartis AG from 2010 until retirement in 2018","Led Pharmaceuticals Division from October 2007 to 2010","Served as Advisor to Blackstone Group L.P.","Executive Vice President, President, and CEO of Heinz Europe from 2002 to 2006","President and CEO of H.J. Heinz Company North America from 1999 to 2002"] | ["EC","CC","FC","RC","Compensation","Executive","Finance (Chair)","Risk and Cybersecurity"] | 2026 |
Companies shown below are based on exact name match for the selected Director
Biography sourced from the proxy statement filing.
Since 2019, Mr. Jimenez has served as Co-Founder and Managing Director of Aditum Bio, a biotechnology-focused venture capital firm. Prior to that, he served as CEO of Novartis AG from 2010 until his retirement in 2018. Mr. Jimenez led Novartis Pharmaceuticals Division from October 2007 to 2010 and its Consumer Health Division in 2007. From 2006 to 2007, he served as Advisor to the Blackstone Group L.P. Mr. Jimenez was also Executive Vice President, President, and CEO of Heinz Europe from 2002 to 2006; and President and CEO of H.J. Heinz Company North America from 1999 to 2002.